Testing effectiveness (Phase 2)UnknownNCT04180501What this trial is testingSRS Sequential Sindilimab in Brain Metastasis of NSLSCWho this might be right forNSCLC Stage IVBrain MetastasesSRS+1 more Xiaorong Dong 25
Large-scale testing (Phase 3)Looking for participantsNCT06956001What this trial is testingFirmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q MutationWho this might be right forEGFRNSCLC (Advanced Non-small Cell Lung Cancer) Allist Pharmaceuticals, Inc. 300
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT05445843What this trial is testingStudy of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.Who this might be right forLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)Ended earlyNCT02580708What this trial is testingPhase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Clovis Oncology, Inc. 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955290What this trial is testingCIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell Carcinoma+13 more Roswell Park Cancer Institute 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117What this trial is testingEvaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Who this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 329
Large-scale testing (Phase 3)Study completedNCT00556712What this trial is testingTarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 889
Large-scale testing (Phase 3)Study completedNCT00403065What this trial is testingDexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By SurgeryWho this might be right forLung CancerMetastatic Cancer Medical Research Council 1,000
Testing effectiveness (Phase 2)Study completedNCT00744900What this trial is testingPemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer University Hospital, Brest 45
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Study completedNCT00564733What this trial is testingFDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer University of Washington 55
Early research (Phase 1)Study completedNCT06863233What this trial is testingCD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerWho this might be right forLung CancerNon Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Study completedNCT04316689What this trial is testingFirst-in-human Study of S-588210 (S-488210+S-488211)Who this might be right forLung CancerHead and Neck CancerBladder Cancer+2 more Shionogi 10
Early research (Phase 1)Active Not RecruitingNCT02817633What this trial is testingTSR-022 in Participants With Advanced Solid Tumors (AMBER)Who this might be right forNeoplasms Tesaro, Inc. 463
Not applicableWithdrawnNCT00897143What this trial is testingIdentifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung CancerWho this might be right forLung CancerMetastatic Cancer Case Comprehensive Cancer Center
Post-approval studies (Phase 4)Looking for participantsNCT06330038What this trial is testingAnesthesia and Non-small Cell Lung Cancer RecurrenceWho this might be right forNon-small Cell Lung CancerSurgeryAnesthesia Samsung Medical Center 5,384
Early research (Phase 1)Ended earlyNCT04892017What this trial is testingStudy of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsWho this might be right forNon-Small Cell Lung CancerAdvanced Solid TumorMetastatic Solid Tumor Deciphera Pharmaceuticals, LLC 91
Not applicableStudy completedNCT04187768What this trial is testingImmunological Profile Changes In Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticHealthy Indiana University 29
Early research (Phase 1)Looking for participantsNCT07181473What this trial is testingEvaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsWho this might be right forLung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more Phrontline Biopharma 200